Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. 

Biotechnology

Neuron23

Neuron23's headquarters in South San Francisco, CA, United States

Nancy Stagliano

Adam Knight

Suresh Dheerendra

Karen L.

Andrew Yost

Ryan Dixon

Luc Desnoyers

Amrit Nagpal

Beth Seidenberg

Kevin Raidy

The Research and Development team at Neuron23 is dedicated to advancing the discovery and optimization of precision medicines for neurological and immunological diseases. Comprising a diverse group of scientists, data analysts, and research associates, the team collaborates to design and conduct experiments, analyze complex data sets, and translate findings into innovative therapeutic strategies. Their work focuses on understanding genetic underpinnings to improve treatment efficacy and patient outcomes.

Research and Development

The Drug Discovery Team at Neuron23 is responsible for identifying and developing innovative therapeutic candidates for genetically defined neurological and immunological diseases. This multidisciplinary team integrates expertise in translational medicine, chemistry, biology, and computational approaches to streamline the drug discovery process, from initial research through to development and manufacturing, ensuring precision and efficacy in their therapeutic solutions.

Drug Discovery Team

The Leadership Team at Neuron23 drives strategic direction and innovation, collaborating across research, translational development, and drug discovery to advance precision medicine initiatives. Comprising experienced executives, including the Founder and Chief Business Officer, this team ensures alignment of scientific goals with business strategies, fostering a culture of collaboration to expedite the development of therapies for neurological and immunological diseases.

Leadership Team

The Clinical Operations Team at Neuron23 is responsible for overseeing the planning, execution, and management of clinical trials for the company's innovative precision medicines. This team ensures adherence to regulatory standards, collaborates with cross-functional teams to integrate data insights, and works closely with investigators to facilitate patient recruitment and retention. Their expertise is crucial for advancing the company's mission to deliver effective treatments for genetically defined neurological and immunological diseases.

Clinical Operations Team

The Finance and Administration team at Neuron23 is responsible for overseeing the financial health of the company and ensuring effective resource management. This includes budgeting, financial reporting, and compliance, as well as managing human resources to foster a productive workplace culture. The team collaborates closely with leadership to align financial strategies with the company’s mission of developing precision medicines.

��

Neuron23

Org chart

Board & advisors

Teams

Research and Development

Drug Discovery Team

Leadership Team

Clinical Operations Team

Finance and Administration

Offices

��������

Neuron23

Org chart

Board & advisors

Teams

Research and Development

Drug Discovery Team

Leadership Team

Clinical Operations Team

Finance and Administration

Offices

Related companies

��